Bird Jeffrey W
CIK 0001250409 Name as filed on the most recent filing
Filed as Bird Jeffrey W (71)
154 transaction lines · from 71 filings · filed 2004-12-17 to 2019-07-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Forty Seven, Inc. 2 filings
- ISSUER Portola Pharmaceuticals Inc 2 filings
- ISSUER Mattersight Corp 37 filings
- ISSUER Threshold Pharmaceuticals Inc 10 filings
- ISSUER Horizon Pharma, Inc. 7 filings
- ISSUER Cardica Inc 4 filings
- ISSUER Corcept Therapeutics Inc 7 filings
- ISSUER Data Domain, Inc. 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
144 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2019-07-22 |
Forty Seven, Inc. FTSV |
P, Open-market purchase | 562,500 acquired | 8.00 | 4,500,000.00 | Form 4, filing 0001225208-19-010430 | |
| 2019-07-22 |
Forty Seven, Inc. FTSV |
P, Open-market purchase | 187,500 acquired | 8.00 | 1,500,000.00 | Form 4, filing 0001225208-19-010430 | |
| 2018-08-23 |
Portola Pharmaceuticals Inc PTLA |
P, Open-market purchase | 50,355 acquired | 26.65 | 1,341,809.68 | Form 4, filing 0001225208-18-012883 | |
| 2018-08-22 |
Portola Pharmaceuticals Inc PTLA |
P, Open-market purchase | 202,082 acquired | 26.09 | 5,273,006.46 | Form 4, filing 0001225208-18-012883 | |
| 2018-08-21 |
Portola Pharmaceuticals Inc PTLA |
P, Open-market purchase | 137,563 acquired | 25.17 | 3,462,570.76 | Form 4, filing 0001225208-18-012883 | |
| 2018-07-02 |
Forty Seven, Inc. FTSV |
P, Open-market purchase | 134,735 acquired | 16.00 | 2,155,760.00 | Form 4, filing 0001225208-18-011382 | |
| 2018-07-02 |
Forty Seven, Inc. FTSV |
P, Open-market purchase | 4,252 acquired | 16.00 | 68,032.00 | Form 4, filing 0001225208-18-011382 | |
| 2017-06-01 |
Portola Pharmaceuticals Inc PTLA |
P, Open-market purchase | 110,642 acquired | 31.85 | 3,523,759.61 | Form 4, filing 0001225208-17-010828 | |
| 2017-06-01 |
Portola Pharmaceuticals Inc PTLA |
P, Open-market purchase | 8,800 acquired | 31.85 | 280,265.04 | Form 4, filing 0001225208-17-010828 | |
| 2017-06-01 |
Threshold Pharmaceuticals Inc THLD |
P, Open-market purchase | 473,077 acquired | 0.57 | 268,423.89 | Form 4, filing 0001225208-17-010827 | |
| 2017-06-01 |
Threshold Pharmaceuticals Inc THLD |
P, Open-market purchase | 37,626 acquired | 0.57 | 21,348.99 | Form 4, filing 0001225208-17-010827 | |
| 2017-06-01 |
Mattersight Corp MATR |
P, Open-market purchase | 203,543 acquired | 3.65 | 742,789.47 | Form 4, filing 0001225208-17-010832 | |
| 2017-06-01 |
Mattersight Corp MATR |
P, Open-market purchase | 16,189 acquired | 3.65 | 59,078.52 | Form 4, filing 0001225208-17-010832 | |
| 2015-11-09 |
Mattersight Corp MATR |
S, Open-market sale | 1,000,000 disposed | 7.29 | 7,290,000.00 | Form 4, filing 0001225208-15-020837 | |
| 2014-10-01 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 226,657 disposed | 3.77 | 854,950.20 | Form 4, filing 0001225208-14-021194 | |
| 2014-10-01 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 11,863 disposed | 3.77 | 44,747.24 | Form 4, filing 0001225208-14-021194 | |
| 2014-06-20 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 3,960 disposed | 4.01 | 15,872.08 | Form 4, filing 0001225208-14-015511 | |
| 2014-06-20 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 10,028 disposed | 4.01 | 40,193.23 | Form 4, filing 0001225208-14-015512 | |
| 2014-06-20 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 10,028 disposed | 4.01 | 40,193.23 | Form 4, filing 0001225208-14-015504 | |
| 2014-06-20 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 3,960 disposed | 4.01 | 15,872.08 | Form 4, filing 0001225208-14-015504 | |
| 2014-06-12 |
Mattersight Corp MATR |
S, Open-market sale | 14,847 disposed | 5.12 | 76,016.64 | Form 4, filing 0001225208-14-015123 | |
| 2014-06-12 |
Mattersight Corp MATR |
S, Open-market sale | 5,853 disposed | 5.12 | 29,967.36 | Form 4, filing 0001225208-14-015123 | |
| 2013-12-13 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 32,075 acquired | 6.50 | 208,487.50 | Form 4, filing 0001225208-14-008229 | |
| 2013-12-13 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 636,598 acquired | 6.50 | 4,137,887.00 | Form 4, filing 0001225208-13-025614 | |
| 2013-12-13 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 32,075 acquired | 6.50 | 208,487.50 | Form 4, filing 0001225208-13-025614 | |
| 2013-12-03 |
Mattersight Corp MATR |
P, Open-market purchase | 225,846 acquired | 3.90 | 880,799.40 | Form 4, filing 0001225208-13-024848 | |
| 2013-12-03 |
Mattersight Corp MATR |
P, Open-market purchase | 9,754 acquired | 3.90 | 38,040.60 | Form 4, filing 0001225208-13-024848 | |
| 2013-11-21 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 104,670 acquired | 6.24 | 652,763.99 | Form 4, filing 0001209191-13-054043 | |
| 2013-11-21 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 46,419 acquired | 6.24 | 289,487.45 | Form 4, filing 0001209191-13-054043 | |
| 2013-05-31 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 260,592 disposed | 5.72 | 1,491,628.61 | Form 4, filing 0001225208-13-013888 | |
| 2013-05-31 |
Threshold Pharmaceuticals Inc THLD |
S, Open-market sale | 12,589 disposed | 5.72 | 72,059.44 | Form 4, filing 0001225208-13-013888 | |
| 2013-03-20 |
Cardica Inc CRDC |
P, Open-market purchase | 981,736 acquired | 1.05 | 1,030,822.80 | Form 4, filing 0001225208-13-008270 | |
| 2013-03-20 |
Cardica Inc CRDC |
P, Open-market purchase | 981,736 acquired | 1.05 | 1,030,822.80 | Form 4, filing 0001225208-13-008249 | |
| 2013-03-20 |
Cardica Inc CRDC |
P, Open-market purchase | 38,166 acquired | 1.05 | 40,074.30 | Form 4, filing 0001225208-13-008249 | |
| 2012-09-25 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 546,200 acquired | 3.49 | 1,906,238.00 | Form 4, filing 0001225208-12-020189 | |
| 2012-09-25 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 29,156 acquired | 3.49 | 101,754.44 | Form 4, filing 0001225208-12-020189 | |
| 2012-09-04 |
Mattersight Corp MATR |
P, Open-market purchase | 185,962 acquired | 5.40 | 1,004,845.67 | Form 4, filing 0001225208-12-019138 | |
| 2012-09-04 |
Mattersight Corp MATR |
P, Open-market purchase | 8,678 acquired | 5.40 | 46,891.57 | Form 4, filing 0001225208-12-019138 | |
| 2012-09-04 |
Mattersight Corp MATR |
P, Open-market purchase | 185,962 acquired | 5.40 | 1,004,845.67 | Form 4, filing 0001225208-12-019143 | |
| 2012-08-30 |
Mattersight Corp MATR |
P, Open-market purchase | 18,640 acquired | 5.31 | 98,948.58 | Form 4, filing 0001225208-12-018807 | |
| 2012-08-30 |
Mattersight Corp MATR |
P, Open-market purchase | 18,640 acquired | 5.31 | 98,948.58 | Form 4, filing 0001225208-12-018803 | |
| 2012-08-30 |
Mattersight Corp MATR |
P, Open-market purchase | 870 acquired | 5.31 | 4,618.31 | Form 4, filing 0001225208-12-018803 | |
| 2012-08-22 |
Mattersight Corp MATR |
P, Open-market purchase | 19,682 acquired | 5.00 | 98,410.00 | Form 4, filing 0001225208-12-018470 | |
| 2012-08-22 |
Mattersight Corp MATR |
P, Open-market purchase | 920 acquired | 5.00 | 4,600.00 | Form 4, filing 0001225208-12-018470 | |
| 2012-08-17 |
Mattersight Corp MATR |
P, Open-market purchase | 3,500 acquired | 4.81 | 16,837.45 | Form 4, filing 0001225208-12-018292 | |
| 2012-08-17 |
Mattersight Corp MATR |
P, Open-market purchase | 3,500 acquired | 4.81 | 16,837.45 | Form 4, filing 0001225208-12-018286 | |
| 2012-03-02 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 5,000 acquired | 3.59 | 17,950.00 | Form 4, filing 0001225208-12-020112 | |
| 2012-03-02 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 645,820 acquired | 3.59 | 2,318,493.80 | Form 4, filing 0001225208-12-006943 | |
| 2012-03-02 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 22,473 acquired | 3.59 | 80,678.07 | Form 4, filing 0001225208-12-006943 | |
| 2012-03-02 |
Horizon Pharma, Inc. HZNP |
P, Open-market purchase | 7,000 acquired | 3.59 | 25,130.00 | Form 4, filing 0001225208-12-006943 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 133
- Open-market sale 11
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. BIRD JEFFREY W, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001250409
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6